Hematopoietic Stem Cell Transplant of a Congenital Dyserythropoietic Anemia Type II Patient: A Rare Report from the Indian Population
- 10 July 2024
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 41 (1) , 194-196
Abstract
No abstract availableFunding Information
- Indian Council of Medical Research (Project NO. 54/2/2020-HUM/BMS)
This publication has 6 references indexed in Scilit:
- Stem cell transplantation for congenital dyserythropoietic anemia: an analysis from the European Society for Blood and Marrow TransplantationHaematologica, 2019
- CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary SpherocytosisCytometry Part B: Clinical Cytometry, 2018
- Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutationsAnnals of Hematology, 2017
- Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B GeneOrphanet Journal of Rare Diseases, 2011
- Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in theSEC23BgeneHuman Mutation, 2009
- Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical dataBlood Reviews, 1998